Career & Training Section

You will find valuable information relating to your career in Ob/Gyn in this indispensable section.

Upcoming conferences 2014

In Canada, in the US and at the international level.

Useful Educational Resources for Obstetrics and Gynaecology

In this guide, you will find lists of textbooks, study guides, video resources and much more.

Residency Survival Guide

Staying well in residency is not always easy. Residents are faced with many professional and personal challenges. In this guide, we provide some strategies for dealing with some of these issues.

Junior Members Committee Guide to Fellowship and Postgraduate Training Opportunities

This guide was developed by the Junior Members Committee as a resource for Canadian residents. The guide lists a description of all available Canadian postgraduate training programs, along with relevant contact information. This guide gets updated yearly by the Junior Members Committee. The September 2011 Edition is linked below. The table of content is interactive as is contains live links. Page 82 "Fellowship Programs by University" is also interactive.

APOG's Subspecialties Booklet

This booklet, published by APOG, is intended to provide you with a brief introduction to a number of subspecialty careers in obstetrics and gynaecology.

Guide to Ob-Gyn Resident Electives

Thinking of applying for an elective? The below document will provide you with valuable contact information for each University.  Good Luck!

Resident Career Guide

In this guide, educational and professional goals are shared for each PGY year. PGY1: The well-rounded resident, PGY2: The medical expert, PGY3: The resource manager, PGY4: The communication expert and PGY5: The expert resident.

Landmark Articles - List by category

General Obs

  1. ORACLE 1. Kenyon et al. Lancet 2001; 357 page 979-988 (Broad spectrum antibiotics for PPROM)
  2. ORACLE 2.  Kenyon et al. Lancet 2001; 357 page 989-994 (Broad spectrum antibiotics for spontaneous pre-term labour)
  3. TERMPROM study. Hannah et al. NEJM 1996; 334 1005-1010 (Induction of labour compared with expectant management for prelabour rupture of membranes at term.) Free Full Text
  4. PPROM At Term: Expectant Management at home or in Hospital. Hannah et al. Obs & Gyne 2000; 96 page 533-538
  5. Mercer Trial. Mercer et al. JAMA 1997; 278 page 989-995 (Antibiotic therapy for reduction of infant morbidity after PPROM)
  6. MAGPIE trial. MAGPIE trial collaborative group.  Lancet 2002; 359 page 1877-1890 (Do women with pre-eclampsia and their babies benefit from magnesium sulfate?)
  7. Planned C/S vs planned vaginal birth for breech presentation at term.  Hannah et al. Lancet 2000; 356 page 1375-1383
  8. Term Breech Trial.  Hannah et al.  AJOG 2004; 191 page 917-927 (Maternal outcomes 2 yrs after planned C/S vs planned vaginal delivery for breech at term)
  9. Haematological problems in pregnancy. Burrows RF. Curr Opin Obset Gynecol 2003; 15: 85-90.
  10. Late vs early clamping of the umbilical cord in full-term neonates. Hutton EK, Hassan ES. JAMA 2007; 297: 1241-52.
  11. Metformin and gestational diabetes. Glueck CJ, Goldenberg N, Streitcher P, Wang P. Current Diabetes Reports 2003; 3: 303-312.
  12. Interventions to help external cephalic version for breech presentation at term. Hofmeyr GJ, Gyte GML. Cochrane Review 2010.


  1. CIPRACT. Althuisius et al. AJOG 2001; 185 page 1106-1112 (Prevention of cervical incompetence- therapeutic cerclage and bed rest vs bed rest alone.)
  2. Progesterone and the risk of preterm birth among women with a short cervix.  Fonseca et al. NEJM 2007; 57 page 462-469 Free Full Text
  3. Trial of 17-alpha-hydroxyprogesterone caproate to prevent prematurity in twins.  Rouse et al. NEJM 2007; 357 page 454-461 Free Full Text
  4. Amnioinfusion for prevention of meconium aspiration syndrome.  Fraser et al. NEJM 2005; 353 page 909-917 Free Full Text
  5. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. Mercer BM et al. JAMA, 1997; 278 page 989-95.
  6. The preterm prediction study: sequential cervical length and fetal fibronectin testing for the prediction of spontaneous preterm birth. Am J Obstet Gynecol. 2000; 182 : p. 636-643.
  7. Do women with pre-eclampsia and their babies, benefit from magnesium sulphate? The Magpie Trial : a randomized placebo-controlled trial. Lancet 2002; 359: 1877-90.

General Gyne

  1. Randomized trial of estrogen and progestin for secondary prevention of coronary heart disease in post menopausal women.  Hulley et al. JAMA 1998; 280  page 605-613 Free Full Text
  2. Risks and benefits of estrogen and progestin in healthy post menopausal women.  JAMA 2002; 288 page 321-333 (Principal results from women’s health initiative RCT) Free Full Text
  3. Cardiovascular disease outcomes during 6.8 yrs of hormone therapy: Heart and estrogen/progestin replacement study follow up (HERS 2).  Grady et al. JAMA 2002; 288 page 49-57 Free Full Text
  4. Non- Cardiovascular disease outcomes during 6.8 yrs of hormone therapy: Heart and estrogen/progestin replacement study follow up (HERS 2). Hulley et al. JAMA 2002; 288 page 58-64 Free Full Text
  5. Effects of conjugated equine estrogen in post menopausal women with hysterectomy (the WHI RCT) JAMA 2004; 291 page 1701-1712 Free Full Text

Gyne Oncology

  1. The 2001 Bethesda system: terminology for reporting results of cervical cytology.  Solomon et al. JAMA 2002; 287 page 2114-2119 Free Full Text
  2. A randomized trial on management of low-grade squamous intraepithelial lesion cytology interpretation.  ASCUS-LSIL triage study group.  AJOG 2003; 188 1393-1400
  3. Vaginal and cervical abnormalities after exposure to stilbestrol in utero. Herbst AL, Kurman RJ, Scully RE. Obstet Gynecol. 1972 Sep;40(3):287-98.
  4. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Cancer. 1987 Oct 15;60(8 Suppl):2035-41.
  5. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, Graham JE. Gynecol Oncol. 1991 Jan;40(1):55-65.
  6. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Fuller AF Jr, Elliott N, Kosloff C, Hoskins WJ, Lewis JL Jr. Gynecol Oncol. 1989 Apr;33(1):34-9.
  7. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women. Skates SJ, Menon U, MacDonald N, Rosenthal AN, Oram DH, Knapp RC, Jacobs IJ. J Clin Oncol. 2003; 21: 206s-210s.
  8. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. Bristow RE, Tamacruz RS, Armstrong DK, Trimble EL, Montz FJ. J Clin Oncol. 2002; 20: 1248-59.
  9. Screening for ovarian cancer: a pilot randomized controlled trial. Jacobs IJ, Skates SJ, MacDonald N, Menon U, Rosenthal AN, Davies AP, Woolas R, Jeyarajah AR, Sibley K, Lowe DG, Oram DH. Lancet. 1999; 353: 1207-10.
  10. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Offit K. NEJM. 2002: 346 (21) : 1609-15. Free Full Text
  11. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL, Walker JL, Gersell D. NEJM 1999; 340: 1154-61. Free Full Text
  12. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M. NEJM 1996; 334 (1) : 1-6. Free Full Text
  13.  Phase III Trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic oncology group study. Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, Mannel RS, DeGeest K, Hartenbach EM, Baergen R. J Clin Oncol 2003; 21: 3194-3200.
  14. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S. NEJM 1999; 340: 1144-53. Free Full Text


  1. Effects on Estrogen on urinary incontinence. JAMA. Free Full Text
  2. TVT, evidence based review, BJOG.
  3. TOT vs TVT. Green Journal. and
  4. Sacrocolpopexy and Burch. CARE study. NEJM. Free Full Text
  5. Two-year outcomes after sacrocolpopexy with and without Burch to prevent stress urinary incontinence. Green Journal. PMC Article
  6. Anal-sphincter disruption during vaginal delivery. Free Full Text
  7. Third degree obstetric anal sphincter tears: risk factors and outcome of primary repair. Free Full Text
  8. A randomized clinical trial comparing primary overlap with approximation repair of third-degree obstetric tears.
  9. Eleven years prospective follow-up of the tension-free vaginal tape procedure for treatment of stress urinary incontinence.
  10. A multicenter study of tension-free vaginal tape (TVT) for surgical treatment of stress urinary incontinence.